Copyright Reports & Markets. All rights reserved.

Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Short Bowel Syndrome (SBS) Drugs Market Overview

  • 1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
  • 1.2 Short Bowel Syndrome (SBS) Drugs Segment by Type
    • 1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Glucagon-Like Peptide-2 (GLP-2)
    • 1.2.3 Growth Hormone
    • 1.2.4 Glutamine
    • 1.2.5 Other
  • 1.3 Short Bowel Syndrome (SBS) Drugs Segment by Application
    • 1.3.1 Short Bowel Syndrome (SBS) Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Retail Pharmacies
  • 1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2016-2027
    • 1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2016-2027
    • 1.4.3 Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers

  • 2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
    • 2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
    • 2.5.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario by Region

  • 3.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
    • 3.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
    • 3.3.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
    • 3.4.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
    • 3.5.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
    • 3.6.2 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
    • 3.7.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Type

  • 4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2016-2021)

5 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Application

  • 5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Merck
    • 6.1.1 Merck Corporation Information
    • 6.1.2 Merck Description and Business Overview
    • 6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Merck Product Portfolio
    • 6.1.5 Merck Recent Developments/Updates
  • 6.2 Takeda
    • 6.2.1 Takeda Corporation Information
    • 6.2.2 Takeda Description and Business Overview
    • 6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Takeda Product Portfolio
    • 6.2.5 Takeda Recent Developments/Updates
  • 6.3 Emmaus Medical
    • 6.3.1 Emmaus Medical Corporation Information
    • 6.3.2 Emmaus Medical Description and Business Overview
    • 6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Emmaus Medical Product Portfolio
    • 6.3.5 Emmaus Medical Recent Developments/Updates
  • 6.4 Ardelyx
    • 6.4.1 Ardelyx Corporation Information
    • 6.4.2 Ardelyx Description and Business Overview
    • 6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Ardelyx Product Portfolio
    • 6.4.5 Ardelyx Recent Developments/Updates
  • 6.5 Naia Pharmaceuticals
    • 6.5.1 Naia Pharmaceuticals Corporation Information
    • 6.5.2 Naia Pharmaceuticals Description and Business Overview
    • 6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Naia Pharmaceuticals Product Portfolio
    • 6.5.5 Naia Pharmaceuticals Recent Developments/Updates
  • 6.6 Nutrinia
    • 6.6.1 Nutrinia Corporation Information
    • 6.6.2 Nutrinia Description and Business Overview
    • 6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Nutrinia Product Portfolio
    • 6.6.5 Nutrinia Recent Developments/Updates
  • 6.7 OxThera
    • 6.6.1 OxThera Corporation Information
    • 6.6.2 OxThera Description and Business Overview
    • 6.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 OxThera Product Portfolio
    • 6.7.5 OxThera Recent Developments/Updates
  • 6.8 Sancilio Pharmaceuticals
    • 6.8.1 Sancilio Pharmaceuticals Corporation Information
    • 6.8.2 Sancilio Pharmaceuticals Description and Business Overview
    • 6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Sancilio Pharmaceuticals Product Portfolio
    • 6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
  • 6.9 Zealand Pharma
    • 6.9.1 Zealand Pharma Corporation Information
    • 6.9.2 Zealand Pharma Description and Business Overview
    • 6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Zealand Pharma Product Portfolio
    • 6.9.5 Zealand Pharma Recent Developments/Updates

7 Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis

  • 7.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
  • 7.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Short Bowel Syndrome (SBS) Drugs Distributors List
  • 8.3 Short Bowel Syndrome (SBS) Drugs Customers

9 Short Bowel Syndrome (SBS) Drugs Market Dynamics

  • 9.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
  • 9.2 Short Bowel Syndrome (SBS) Drugs Growth Drivers
  • 9.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
  • 9.4 Short Bowel Syndrome (SBS) Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Type (2022-2027)
  • 10.2 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Application (2022-2027)
  • 10.3 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Glucagon-Like Peptide-2 (GLP-2)
    Growth Hormone
    Glutamine
    Other

    Segment by Application
    Hospitals
    Clinics
    Retail Pharmacies

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Merck
    Takeda
    Emmaus Medical
    Ardelyx
    Naia Pharmaceuticals
    Nutrinia
    OxThera
    Sancilio Pharmaceuticals
    Zealand Pharma

    Buy now